41
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2351518
Trilogy Therapeutics is a Biopharmaceutical company
About the Company
Trilogy Therapeutics was founded in 2015 to develop lung targeted therapy to prevent and treat severe respiratory diseases. Many respiratory diseases are treated with intravenous or oral agents so that only a relatively small amount of drug is actually delivered to the lung. As the lung is the primary site of infection, the efficacy of these
systemic treatments is suboptimal. Trilogy Therapeutic is focused on achieving optimal efficacy by developing lung compatible formulations that are suitable for aerosolization in order to target deposition at the site of disease and avoid the side-effects of systemic distribution.
